Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: a phase 3 randomized, controlled trial in Senegalese children.

MLA

Riveau, Gilles, et al. “Safety and Efficacy of the RSh28GST Urinary Schistosomiasis Vaccine: A Phase 3 Randomized, Controlled Trial in Senegalese Children.” PLoS Neglected Tropical Diseases, vol. 12, no. 12, Dec. 2018, pp. 1–22. EBSCOhost, https://doi.org/10.1371/journal.pntd.0006968.

APA

Riveau, G., Schacht, A.-M., Dompnier, J.-P., Deplanque, D., Seck, M., Waucquier, N., Senghor, S., Delcroix-Genete, D., Hermann, E., Idris-Khodja, N., Levy-Marchal, C., Capron, M., & Capron, A. (2018). Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: a phase 3 randomized, controlled trial in Senegalese children. PLoS Neglected Tropical Diseases, 12(12), 1–22. https://doi.org/10.1371/journal.pntd.0006968

Chicago

Riveau, Gilles, Anne-Marie Schacht, Jean-Pierre Dompnier, Dominique Deplanque, Modou Seck, Nawal Waucquier, Simon Senghor, et al. 2018. “Safety and Efficacy of the RSh28GST Urinary Schistosomiasis Vaccine: A Phase 3 Randomized, Controlled Trial in Senegalese Children.” PLoS Neglected Tropical Diseases 12 (12): 1–22. doi:10.1371/journal.pntd.0006968.